secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2026-06-29T20:40:44+00:00
Accession:  0001193125-26-288600
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax adopts CIC/Severance Plans; amends CEO Giordano's agreement
-----------------------------------------------------------------

- Board adopted double-trigger Change in Control Plan and Severance Plan on June 26, 2026.
- CEO Giordano: 18 months' base salary + target bonus + accelerated vesting on CIC termination.
- Executives Staab and Rich: 12 months' base salary + COBRA on CIC; non-CIC severance includes 12-month base plus extra base per year of service up to 12 additional months.
- Benefits under plans and amendments conditioned on execution of release of claims.
- Executive officers excluded from new plans; covered via individual amended agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000119312526288600/0001193125-26-288600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000119312526288600/d251626d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-288600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer